Absorption |
Blood-Brain Barrier | BBB+ | 0.5209 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2- | 0.8316 |
P-glycoprotein Substrate | Substrate | 0.8032 |
P-glycoprotein Inhibitor | Inhibitor | 0.6147 |
Inhibitor | 0.7848 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7679 |
Distribution |
Subcellular localization | Mitochondria | 0.4330 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.6451 |
CYP450 2D6 Substrate | Substrate | 0.5741 |
CYP450 3A4 Substrate | Substrate | 0.7131 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8199 |
CYP450 2C9 Inhibitor | Inhibitor | 0.6168 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8926 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8297 |
CYP450 3A4 Inhibitor | Inhibitor | 0.8998 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.6559 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8225 |
Inhibitor | 0.7828 |
AMES Toxicity | Non AMES toxic | 0.5717 |
Carcinogens | Non-carcinogens | 0.5184 |
Fish Toxicity | High FHMT | 0.9884 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9154 |
Honey Bee Toxicity | Low HBT | 0.6907 |
Biodegradation | Not ready biodegradable | 0.9072 |
Acute Oral Toxicity | III | 0.5206 |
Carcinogenicity (Three-class) | Non-required | 0.5970 |